BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38492490)

  • 1. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
    Ying C; Zhang L; Jin X; Zhu D; Wu W
    Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report.
    Kuge T; Fukushima K; Matsumoto Y; Abe Y; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Kawasaki T; Matsuki T; Kagawa H; Motooka D; Tsujino K; Miki M; Miki K; Kitada S; Nakamura S; Iida T; Kida H
    BMC Infect Dis; 2020 Nov; 20(1):888. PubMed ID: 33238934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
    Haworth CS; Floto RA
    Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of nontuberculous mycobacterial (NTM) lung disease.
    Philley JV; Griffith DE
    Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
    Kwon YS; Daley CL; Koh WJ
    Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
    [No Abstract]   [Full Text] [Related]  

  • 6. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease.
    van Ingen J
    Clin Chest Med; 2015 Mar; 36(1):43-54. PubMed ID: 25676518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and risk factors associated with NTM pulmonary and extrapulmonary infections in a high tuberculosis endemic Region.
    Wani SR; Wattal C; Raveendran R
    Indian J Med Microbiol; 2020; 38(2):169-175. PubMed ID: 32883930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
    Cadelis G; Ducrot R; Bourdin A; Rastogi N
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
    Philley JV; Griffith DE
    Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.
    Hu C; Huang L; Cai M; Wang W; Shi X; Chen W
    BMC Infect Dis; 2019 Sep; 19(1):764. PubMed ID: 31477038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
    Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
    Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis.
    López-Varela E; García-Basteiro AL; Santiago B; Wagner D; van Ingen J; Kampmann B
    Lancet Respir Med; 2015 Mar; 3(3):244-56. PubMed ID: 25773213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
    Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
    Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of clinically important non tuberculous mycobacteria (NTM) from pulmonary samples through one-step multiplex PCR assay.
    Singh K; Kumari R; Tripathi R; Gupta S; Anupurba S
    BMC Microbiol; 2020 Aug; 20(1):267. PubMed ID: 32847517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
    Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
    Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontuberculous mycobacteria infections in immunosuppressed hosts.
    Henkle E; Winthrop KL
    Clin Chest Med; 2015 Mar; 36(1):91-9. PubMed ID: 25676522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals.
    Wang J; Xu H; Wang X; Lan J
    Front Cell Infect Microbiol; 2022; 12():1083497. PubMed ID: 36760234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the sputum microbiome between patients with stable nontuberculous mycobacterial pulmonary disease and patients requiring treatment.
    Song MJ; Kim DH; Kim SY; Kang N; Jhun BW
    BMC Microbiol; 2024 May; 24(1):172. PubMed ID: 38760693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atypical mycobacteria and pulmonary involvement in infectious diseases].
    Camarena Miñana JJ; Pellicer RG
    Enferm Infecc Microbiol Clin; 2011 Dec; 29 Suppl 5():66-75. PubMed ID: 22305672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.